Premium
Lines of therapy before autologous stem cell transplant and CAR‐T affect outcomes in aggressive Non‐Hodgkin's lymphoma
Author(s) -
Khurana Arushi,
Hathcock Matthew,
Habermann Thomas M.,
Al Saleh Abdullah S.,
Gandhi Sangeetha,
Truong Tuan,
Bennani N. Nora,
Paludo Jonas,
Villasboas Jose C.,
Ansell Stephen M.,
Inwards David J.,
Porrata Luis F.,
Johnston Patrick B.,
Micallef Ivana,
Lin Yi
Publication year - 2021
Publication title -
american journal of hematology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.456
H-Index - 105
eISSN - 1096-8652
pISSN - 0361-8609
DOI - 10.1002/ajh.26293
Subject(s) - medicine , chimeric antigen receptor , oncology , population , lymphoma , immunotherapy , cancer , environmental health